Table 6.
Substancea | Deduced pharmacological functionsb | Matching biological activities reported in the studiesc | Study typed | Stud.e |
---|---|---|---|---|
Agar wood | Analgesic | Anti-inflammatory, 1× | In vitro | 1 |
Anti-inflammatory | ||||
Antimicrobial | ||||
Immunomodulatory | ||||
Wound healing promotion | ||||
Cherry gum | Antitussive | [Indirect hepatoprotective, 1×] | in vivo1 | 2 |
Beneficial effect on liver or kidney diseases | [Improved metabolic profile in chronic renal failure, 1×] | In vivo1 | ||
Bronchodilatating | ||||
Expectorant | ||||
Stone-dissolving/-expelling | ||||
Vision improving effects | ||||
Frankincense | Analgesic | Anti-inflammatory, 3× | In vitro, in vivo | 3 |
Anti-inflammatory | Decrease of cytokine levels (immunomodulatory), 1× | In vivo | ||
Immunomodulatory | ||||
Galbanum | Abortifacient | Spasmolytic | In vitro | 1 |
Effects on uterine contractility | ||||
Gum arabic | Antibiotic | Improved recovery rates from diarrhea, 1× | In vivo | 4 |
Anti-inflammatory | Proabsorptive (antisecretory), 2× | In vivo | ||
Antimotility | No significant antidiarrheal effects, 1× | Clinical2 | ||
Antisecretory | ||||
Bulk-forming effect | ||||
Ladanum | Analgesic | Antibacterial, 2× | In vitro | 4 |
Antifungal | Antioxidant (anti-inflammatory), 1× | In vitro3 | ||
Anti-inflammatory | No significant anti-inflammatory effect, 2× | In vitro3, in vivo4 | ||
Antimicrobial | ||||
Effects with a beneficial action | ||||
on the hair cycle | ||||
5-Alpha-reductase inhibition | ||||
Pine resin | Analgesic | Analgesic, 1× | In vivo | 3 |
Anti-inflammatory | Anti-inflammatory, 2× | In vivo4, in vivo3 | ||
Immunomodulatory | ||||
Plum gum | Antibiotic | No data available | – | 0 |
Stone-dissolving/-expelling | ||||
Scammony | Antibiotic | Antibacterial (antibiotic), 1× | In vitro4 | 1 |
Antimalarial | ||||
Antiviral | ||||
Cathartic | ||||
Solid storax | Analgesic | No data available | – | 0 |
Anti-inflammatory | ||||
Antimicrobial | ||||
Immunomodulatory | ||||
Wound healing promotion | ||||
Sumatra or Siam benzoin | Analgesic | Antifungal, 1× | Case reports2,4 | 2 |
Anti-inflammatory | Phagocytotic (antibacterial), 1× | In vivo | ||
Antimicrobial | ||||
Immunomodulatory | ||||
Wound healing promotion | ||||
Terebinth resin | Alpha-receptor antagonistic effect | Antibacterial, 1× | In vitro4 | 7 |
Analgesic | Antimicrobial (antibiotic), 1× | In vitro | ||
Antibiotic | Anti-hypernociceptive (analgesic), 1× | In vivo4 | ||
Anticancer | Anti-inflammatory, 3× | In vivo4, in vivo3 | ||
Anti-inflammatory | Inhibition of LDL oxidation (anti-inflammatory), 1× | In vitro | ||
Antimicrobial | Leucotriene inhibition (anti-inflammatory), 1× | In vitro4 | ||
Antimotility | ||||
Antisecretory | ||||
Wound healing promotion | ||||
5-Alpha-reductase inhibition |
aCorresponding to the homonymous column in Table 5.
bCorresponding to the homonymous column in Table 5. All pharmacological functions referring to the same substance were consolidated.
cWhere appropriate the deduced pharmacological function to which the reported activity was cross-references is added in parenthesis. Activities in squared brackets refer to studies conducted with an analogous substance from a taxonomically unrelated species (see footnote 4). The figure indicates the number of studies reporting the corresponding activity.
cType of the study reporting the corresponding activity.
dNumber of studies included in the comparison.
The study was conducted with: 1gum arabic, 2a compound preparation that included additional further active constituents, 3a different plant part, 4isolated compounds only..